Antitumor immunity by magnetic nanoparticle-mediated hyperthermia (Q38260733)

1 September 2017

1 reference

title

Antitumor immunity by magnetic nanoparticle-mediated hyperthermia (English)

1 reference

1 September 2017

0 references

magnetite nanoparticle

0 references

magnetic nanoparticle

1 reference

Takeshi Kobayashi

1 reference

1 September 2017

Kazuhiro Kakimi

series ordinal

1 reference

1 September 2017

Eiichi Nakayama

series ordinal

1 reference

1 September 2017

Kowichi Jimbow

series ordinal

1 reference

1 September 2017

publication date

1 August 2014

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

1 September 2017

page(s)

1715-1726

1 reference

Heating the patient: a promising approach?

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

The cellular and molecular basis of hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Medical application of functionalized magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Cancer hyperthermia using magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Physics of heat generation using magnetic nanoparticles for hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Magnetically mediated hyperthermia: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Clinical applications of magnetic nanoparticles for hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Optimizing magnetic nanoparticle design for nanothermotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Cationic albumin-conjugated magnetite nanoparticles, novel candidate for hyperthermia cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Hyperthermia mediated liposomal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Genomic DNA released by dying cells induces the maturation of APCs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Uric acid promotes an acute inflammatory response to sterile cell death in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Induced cell toxicity originates dendritic cell death following magnetic hyperthermia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Biological rationales and clinical applications of temperature controlled hyperthermia--implications for multimodal cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Old and new facts about hyperthermia-induced modulations of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

21 January 2018

The heat-shock response

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

The chaperone function of hsp70 is required for protection against stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Heat shock proteins and thermotolerance; a comparison of induction kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Heat shock proteins transfer peptides during antigen processing and CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Heat shock protein 70-associated peptides elicit specific cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Roles of heat-shock proteins in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

CD40-independent engagement of mammalian hsp70 by antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Sensitivity of human natural killer cells to hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

A novel hyperthermia treatment for bone metastases using magnetic materials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Computational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.106

21 January 2018

Identifiers

DOI

10.2217/NNM.14.106

1 reference

1 September 2017

1 reference